Congress restores coverage
This thesis follows legislation that restores federal funding for health coverage, whether through Medicaid or subsidies for individual-market plans. When coverage support lapses, hospitals treat more uninsured patients and write off more unpaid care, and insurers lose enrollees. If Congress reverses that, the mechanism runs the other way: more patients arrive with a payer behind them, bad-debt expense falls, and insured enrollment rises. The debate over these programs is live, which is why the question matters now. A portfolio under this thesis selects companies whose revenue moves directly with that restored coverage. That means hospital operators, especially those with large Medicaid and self-pay populations, and health insurers that administer managed Medicaid plans or sell individual-market policies, where the added premium revenue exceeds the cost of treating new members. Businesses without material exposure to the restored coverage, such as device makers or pharmacies, are excluded.
Molina Healthcare is a government-programs managed-care carrier: FY2025 premium revenue of $43.1b split Medicaid $32.2b (75%), Medicare $6.2b (14%), Marketplace $4.5b (10%). medicaid plus exchange books were ~85% of premiums, and the medicare segment is being narrowed to dual-eligible (medicaid-linked) members after the 2026 MAPD exit. this is the archetype of the portfolio angle — a carrier whose premium base is led by managed Medicaid contracts. two offsets to a full 1.0: the remaining medicare book answers to a different policy lever, and the exchange book is being deliberately shrunk (membership 655k → 267k through Q3 2026, ~$1b of marketplace revenue targeted for removal in 2027), so the enhanced-subsidy leg of the thesis would be captured only partly. tier 0.9 — pure play on the medicaid leg, diminishing exposure on the exchange leg.
Centene is a government-programs managed care carrier. in Q3 2026 premium and service revenue of $45.1b split Medicaid $24.0b (53%), Commercial $8.7b (19%, of which Marketplace is 3.4m of 3.9m members), Medicare $11.3b (25%, much of it PDP) and Other $1.1b. Medicaid plus exchange is therefore roughly 70% of premiums — the carrier is Medicaid-led with a large exchange book, which is this portfolio's angle. it is also the clearest already-hit name: marketplace membership fell from 5.8m to 3.4m after enhanced premium tax credits expired at the start of 2026, and Medicaid membership has shrunk under redeterminations and policy changes, so restored subsidies and Medicaid financing act directly on its two largest books. the ~25% Medicare segment (MA plus PDP) does not express the thesis, which keeps it below pure play → 0.8.
Acadia Healthcare is a single-segment US behavioral facility operator — 277 facilities, 12,500+ beds across acute inpatient psychiatric (55% of 2025 revenue), specialty, comprehensive treatment centers and residential treatment. payer mix is the most Medicaid-heavy of the listed facility operators: 57.7% of FY2025 revenue and 62.4% in Q2 2026, with Medicare 14.1% and commercial 21.5%. for this portfolio's angle — behavioral operators with material Medicaid share — that is close to the archetype, so the tier sits well above material exposure. it is not 1.0 because the thesis channel is Medicaid financing (supplemental and state-directed payments, roughly 7% of revenue per third-party analysis, plus provider-tax room) rather than uninsured-to-paid conversion: self-pay and other payors are under 3.5% of revenue, so the bad-debt lever is small, and much of its patient base is exempt from OBBBA eligibility rules, muting the enrollment lever.
construction analyst: on the researcher's own evidence the thesis-bearing hospital segment is about 56% of adjusted ebitda, the hospital payer mix is roughly 70% managed care with uninsured at 0.1% of net patient revenue, and the quantified exchange-subsidy sensitivity is about $250m or 5-6% of consolidated ebitda. that is material exposure diluted by uspi's commercially insured elective surgery book, which the researcher's own caveat says pushes toward 0.5. a tenet-like hospital book on its own would score around hca's 0.7, and roughly half the earnings base sits outside it, so 0.5 is the honest number; it keeps the name in the core and broad portfolios but out of the pure hospital list.
Oscar Health is a single-segment health insurer that sells individual and family plans through the federal and state ACA exchanges, with about 3.2 million effectuated members at march 2026 and premium revenue that includes federal premium subsidies directly. it has no managed Medicaid, Medicare Advantage or employer group book of scale; its ICHRA-funded individual plans still run through the individual market. the 10-Q states the enhanced premium tax credits expired at end-2025 and reduced both marketplace participation and Oscar's membership after the 2026 open enrollment — the exact lever the thesis restores. an exchange-led carrier whose entire premium base is the individual market is the pure expression of this portfolio's angle → 1.0.
Universal Health Services runs 29 acute care hospitals and 346 inpatient behavioral health centers. acute care is about 57% of consolidated net revenue; behavioral is about 43% and earns over half of pretax profit, with roughly 6% of sales in the UK. consolidated payer mix is Medicaid plus managed Medicaid near 29% of net revenue — well above HCA's ~12% — with heavy Texas (non-expansion), Nevada and California (expansion) concentration and about 1.5 billion dollars of annual Medicaid supplemental net benefit that OBBBA cuts by 432 to 480 million dollars by 2032. lost enhanced premium tax credits are converting exchange patients to self-pay one-for-one, an ~85 million dollar 2026 pretax drag. against this portfolio's acute-care angle the acute segment is a direct fit but only a bit over half the business; behavioral Medicaid exposure counts at lower strength and the UK and Talkspace pieces do not express the thesis → material exposure, 0.6.
HCA Healthcare is a single-segment US acute-care hospital operator (190 hospitals, 19 states, sic 8062), so the whole business sits in leg 1. the thesis link is measured, not narrative: q3 2026 10-Q shows Medicaid plus managed Medicaid at 13.7% of revenue, uninsured at 8% of admissions (up from 6%), and the company attributes a roughly $400 million quarterly hit to income before taxes — about 10% of adjusted EBITDA — to patients who lost exchange coverage migrating to uninsured. 73% of uninsured admissions are in Texas and Florida, non-expansion states, so restored premium tax credits are the main channel and Medicaid expansion funding a secondary one; Medicaid supplemental payments add a further $600 to 800 million net benefit in 2026 that is guided down for 2027.